Pefloxacin and its derivative, novel inhibitors of the SARS-CoV-2 Main protease (3CLpro) and their pharmacokinetics prediction: An in silico analysis
Crossref DOI link: https://doi.org/10.29328/journal.apps.1001030
Published Online: 2022-07-12
Published Print: 2022-07-12
Update policy: https://doi.org/10.29328/crossmark-policy
Emmanuel Oluwaseun, Adediran https://orcid.org/0000-0001-7601-6357
